biomedicina slovenica


"CANCER VACCINES" : 38

  1. Švajger Urban; Rožman Primož
    Mixed cultures of allogeneic dendritic cells are phenotypically and functionally stable - a potential for primary cell-based "off the shelf" product generation
    2021
  2. Tešić Nataša; Pekle Simonič Iza; Roškar Katja; Rožman Primož; Švajger Urban
    Dendritic cells generated in the presence of platelet lysate have a reduced type 1 polarization capacity
    2019
  3. Obermajer Nataša
    Priprava protitumorskih cepiv na osnovi dendritičnih celic
    [Generation of dendritic cells as cancer vaccines]
    2011
  4. Novaković Srdjan; Cerkovnik Petra; Jezeršek Novaković Barbara; Stegel Vida
    Long-lasting antitumor immunity triggered by the vaccination with CpG ODNs and irradiated tumor cells
    2010
  5. Novaković Srdjan; Cerkovnik Petra; Jezeršek Novaković Barbara
    Combination of CpG ODNs and radiotherapy efficiently delayed growth of subcutaneous B16F1 tumors
    2009
  6. Novaković Srdjan; Stegel Vida; Jezeršek Novaković Barbara
    Tumor vaccine composed of CpG ODN class C and irradiated tumor cells triggers preventive and therapeutic antitumor effect in vivo
    2008
  7. Cerkovnik Petra
    Značilnosti delovanja protitumorske vakcine pripravljene iz sintetičnih oligodeoksinukleotidov in obsevanih tumorskih celic na modelu melanoma poskusnih živali
    2011
  8. Cerkovnik Petra; Jezeršek Novaković Barbara; Stegel Vida; Novaković Srdjan
    Tumor vaccine composed of CpG ODN class C and irradiated tumor cells up-regulates the expression of genes characteristic of mature dendritic cells and of memory cells
    2011
  9. Novaković Srdjan
    Tumorske vakcine
    2011
  10. Zorec Robert; Kreft Marko; Gabrijel Mateja
    Method for determining the quantity and quality of hybridomas
    2010
  11. Cerkovnik Petra; Jezeršek Novaković Barbara; Stegel Vida; Novaković Srdjan
    Tumor vaccine composed of C-class CpG oligodeoxynucleotides and irradiated tumor cells induces long-term antitumor immunity
    2010
  12. Uršič-Vrščaj Marjetka; Kubelj Monika
    To cepivo je usmerjeno neposredno proti raku
    2006
  13. Snoj Nataša; Čufer Tanja
    Biološko in tarčno zdravljenje karcinomov
    2007
  14. Novaković Srdjan; Stegel Vida; Kopitar Andreja Nataša; Ihan Alojz; Jezeršek Novaković Barbara
    Phagocytic cells are critical for the development of a long-lasting anticancer immunity
    2006
  15. Frank Mojca; Ihan Alojz
    Tumor vaccines
    [Tumorska cepiva]
    2006
  16. Stegel Vida
    Priprava in uporaba tumorskih cepiv iz mononuklearnih celic na eksperimentalnih tumorskih modelih
    2006
  17. Oven Irena
    MHC class II molecules and tumour immunotherapy
    [Pomen molekul MHC pri imunoterapiji tumorjev]
    2005
  18. Novaković Srdjan
    Predstavitev Oddelka za molekularno diagnostiko
    2005
  19. Novaković Srdjan
    Kratek pregled trenutnega stanja na področju tumorskih vakcin in povzetek našega dela na tem področju
    2005
  20. Fonda Irena
    Spreminjanje biološke aktivnosti dejavnika tumorske nekroze alfa (TNF-alfa) in njegovih analogov
    [Changing biological activity of tumour necrosis factor alpha (TNF-alpha) and its analogues]
    2005
  21. Novaković Srdjan; Stegel Vida; Kopitar Andreja; Ihan Alojz; Jezeršek-Novaković Barbara
    Generation of hybdridomas by electrofusion in hypoosmolar conditions
    2004
  22. Stegel V; Kopitar A; Novaković S
    Priprava hibridomov iz monocitov in tumorskih celic
    2004
  23. Jeras Matjaž
    Gojenje človeških celic in tkiv in vitro za eksperimentalne in terapevtske namene
    2004
  24. Novaković Srdjan
    A brief overview of the current status of tumor vaccines and our experience in this line of work
    [Kratek pregled tumorskih cepiv in naše izkušnje]
    2004
  25. Fleischmann William Robert; Wu Tzu G
    Development of a vaccine against cancers
    [Razvoj cepiva proti raku]
    2004
  26. Novaković Srdjan
    Current status in the field of tumor vaccines
    2003
  27. Novaković Srdjan; Čegovnik Urška; Jezeršek-Novaković Barbara
    In vivo transfection of tumors with cDNA encoding hTNF-alpha increases the effect of the irreadiation therapy
    2002
  28. Novaković Srdjan; Jezeršek-Novaković Barbara
    A brief overview of the tumor vaccines through the last decade
    [Kratek pregled priprave tumorskih vakcin v zadnjem desetletju]
    2002
  29. Novaković Srdjan
    Tumorske vakcine
    2001
  30. Novaković Srdjan
    Tumor vaccines against malignant melanoma
    2000
  31. Novaković Srdjan
    Tumor vaccines against melignant melanoma: two different approaches
    2000
  32. Novaković S; Čegovnik U; Menart V; Galvani V; Wraber B
    Construction of an expression cassette with hTNF-alpha gene for transient expression of the gene in mammalian cells
    2001
  33. Čegovnik Urška
    Priprava ekspresijske kasete z genom hTNFalfa za prehodno izražanje v sesalskih celicah
    2000
  34. Novaković S; Jezeršek B
    Irradiated tumor cells admixed with MVE-2 could be effective in prevention of tumor development in mice
    1999
  35. Novaković Srdjan; Ihan Alojz; Jezeršek Barbara
    Effectiveness of a simply designed tumor vaccine in prevention of malignant melanoma development
    1999
  36. Nestle Frank O
    Ocena rezultatov vakcinacije z dendritičnimi celicami pri zdravljenju raka pri ljudeh
    [Critical issues regarding dendritic cell vaccination for human cancer]
    1999
  37. Novakovič Srdjan; Ihan Alojz; Wraber Branka; Jezeršek Barbara
    An effective tumor vaccine against malignant melanoma: irradiated autologous tumor cells admixed with MVE-2
    1999
  38. Novaković Srdjan; Jezeršek Barbara
    Simple but extremely effective autologous tumor vaccines
    [Enostavne avtologne tumorske vakcine]
    1998



New search      Comments      Top of page Institute for Biostatistics and Medical Informatics